In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...

In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Wegovy is taken via an injection once a week. Should you meet the eligibility criteria and are prescribed Wegovy, your healthcare team will give you more information about how to take it and how to ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Wegovy comes as a liquid solution inside a prefilled single-dose pen for subcutaneous injection (an injection under your skin). For more details on Wegovy, including limitations of use ...

The active ingredient in Wegovy is semaglutide. The drug comes as an injection under your skin that you give yourself in your abdomen, thigh, or upper arm. Keep reading to learn about the common ...

Novo Nordisk markets its semaglutide medicines as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes (T2D) and Wegovy injection for weight management. The company competes with ...